The Daudi strain of Epstein-Barr virus (EBV) possesses a genomic deletion, relative to the B95-8 EBV prototype, that removes the entire Epstein-Barr virus nuclear antigen 2 (EBNA2) open reading frame (ORF) and the sequences encoding the carboxy terminus of EBNA5. Immunoblot analysis carried out in this study indicates that two species of EBNA5 (31 K and 37K) are expressed in Daudi cells. Nucleotide sequence analysis of Daudi cDNA clones has confirmed that, as a consequence of the genomic deletion, exons usually appearing further downstream in EBNA messages (exons U or HF) are spliced directly onto the truncated EBNA50RF. Furthermore, the use of alternative splicing suggests that the two EBNA5 species expressed in Daudi cells possess different carboxy termini.
The Daudi strain of Epstein-Barr virus (EBV) possesses a genomic deletion, relative to the B95-8 EBV prototype, that removes the entire Epstein-Barr virus nuclear antigen 2 (EBNA2) open reading frame (ORF) and the sequences encoding the carboxy terminus of EBNA5. Immunoblot analysis carried out in this study indicates that two species of EBNA5 (31 K and 37K) are expressed in Daudi cells. Nucleotide sequence analysis of Daudi cDNA clones has confirmed that, as a consequence of the genomic deletion, exons usually appearing further downstream in EBNA messages (exons U or HF) are spliced directly onto the truncated EBNA50RF. Furthermore, the use of alternative splicing suggests that the two EBNA5 species expressed in Daudi cells possess different carboxy termini.
Infection of human B lymphocytes with Epstein-Barr virus (EBV) predominantly results in a latent infection, with little production of virions, and a concomitant immortalization of the infected cells. There are at least nine virus-encoded proteins expressed during latent infection, and the genes encoding six of these, EpsteinBarr virus nuclear antigen 1 to 6 (EBNAs 1 to 6) are transcribed from a complex transcriptional unit spanning the left-hand 100 kbp of the viral genome, as conventionally depicted. Transcription in most B cells is driven by either of two promoters, one in the BamHI C fragment (Cp) and the other in the BamHI W fragment (Wp). Transcripts initiating at Wp and Cp contain one and two unique exons at their 5' ends, respectively. These are spliced to a variable number of repeated exons (W1 and W2) encoded within the BamHI W repeat. The W2 exons splice either to another Wl exon, or to two or three exons encoded within the adjacent BamHI Y fragment (Y1, Y2 and Y3). The Y2 or Y3 exon is in turn spliced to, or contiguous with, unique 3' sequences which include those encoding EBNAs 1, 2, 3, 4 and 6 (reviewed in Speck & Strominger, 1989) . The major part of the remaining member of the EBNA family, EBNA5, is encoded by the W1 and W2 exons, and its carboxy terminus is specified by exons Y1 and Y2 (Dillner et al., 1986; Sample et al., 1986; Speck et al., 1986; Wang et al., 1987 0001-1029 © 1992 SGM present in the 5' leader sequences of messages that specify the other EBNAs. It is noted, however, that such messages can only encode EBNA5 when a translational initiation codon is created by a splicing event at the 5' end of the mRNA (Sample et al., 1986; Speck et al., 1986; Rogers et al., 1990) . Both the Daudi and P3HR-1 strains of EBV possess non-identical but similar deletions in their genomes that remove the BamHI Y fragment and adjacent sequences, resulting in the fusion of sequences in BamHI W and H (Jeang & Hayward, 1983; Jones et al., 1984) . The deletions include the YH exon encoding EBNA2, and exons Y1 and Y2 encoding the carboxy terminus of EBNA5 (Fig. 1) . In the case of Daudi, the last W2 exon is also absent. Deletion of the W2 and Y exons is predicted to result in the splicing of exons that usually appear further downstream directly onto W1, thus endowing the Daudi EBNA50RF with a novel 3' end. The aim of this study was to identify these exons, allowing the prediction of the amino acid sequence of Daudi EBNA5.
First, to confirm that the Daudi cell line under investigation did indeed express EBNA5, protein extracts were prepared from these cells and subjected to immunoblotting using either the JF186 monoclonal antibody (MAb) (Finke et al., 1987) or an afffinitypurified antibody preparation against EBNA5 (Gregory et al., 1990) . The affinity-purified antibody reacted with three protein species in Daudi cells, of Mr 29K, 31K and 37K. A species of 29K was, however, also detected in proteins extracted from the EBV-negative cell line, Ramos (Fig. 2) . It was assumed, therefore, that the protein of similar size in Daudi cells was a cross-reacting cellular species. The JF186 MAb, on the other hand, failed to react with any Daudi proteins (data not shown). Second, to determine the structure of the Daudi EBNA5 ORF, a strategy was devised by which cDNA copies of EBNA5 messages could be amplified by the polymerase chain reaction (PCR). Oligonucleotide primers were designed which correspond to sequences within the numerous exons constituting the mRNAs derived from the long rightward primary transcript (Speck & Strominger, 1989) . Most of the primers were constructed so as to incorporate restriction endonuclease recognition sites into the termini of the amplified products to facilitate their ligation into cloning vectors. The sequences and locations of the primers are given in Fig. 3 and its legend. Cytoplasmic RNA was prepared from exponential phase Daudi cultures by the method of Favaloro et al. (1980) , 'reverse-transcribed" into cDNA in the presence of random hexamer oligonucleotides and subjected to PCR as described by Kawasaki (1990) .
Amplification products were subjected to Southern blotting and probed with a 32p-labelled oligodeoxynucleotide corresponding to a sequence within the Wl exon (5' GAGACCGAAGTGAAGTCCCT 3'). Positive cDNAs were cloned into pBluescript KS (Stratagene) and M 13 vectors by standard methods (Sambrook et al., 1989) , and sequenced by the dideoxynucleotide chain termination method (Sanger et al., 1977) . The structures of five cDNA clones determined by this procedure are presented in Fig. 3 . Nucleotide sequence analysis demonstrated two mutations in the Daudi Wl exon relative to the prototype B95-8 sequence. These were GGC-+GTC and ACC--+GCC mutations resulting in Gly-+Val and Thr--+Ala amino acid substitutions at positions 8 and 12 of the Wl-encoded peptide, respectively. These two mutations are also apparent in the sequence of the P3HR-1 W1 exon (Jenson et al., 1987) . Since the JF186 MAb (Finke et al., 1987) was generated following immunization with a peptide corresponding to most of the B95-8 Wl-encoded sequence, it is possible that these mutations explain the lack of reactivity of this antibody with either the P3HR-1 or Daudi EBNA5 species (this study; Finke et al., 1987) . Since clones WFH1, WUL1 and WUE3.1 do not contain the splice junction creating the translational initiation codon required for EBNA5 expression, it is unclear whether these clones represent true EBNA5 mRNAs. To date, analysis of c D N A clones has shown that all m R N A species capable of encoding EBNA5 also contain the EBNA2 exon (Sample et al., 1986; Speck et al., 1986 ). However, it is possible that EBNA5-encoding mRNAs may also contain one of the other EBNA ORFs instead of EBNA2. The detection of EBNA5 species in Daudi and P3HR-1 cells (this study; Rowe et al., 1987; Wang et al., 1987) clearly demonstrates that these proteins can be expressed from m R N A s lacking the E B N A 2 0 R F .
Characterization of c D N A clones WUL1, WUE3.1 and WHF1 indicated that either exon U or exon HF can be spliced directly onto W1. The consequence of this for EBNA5 structure is that the 89 amino acids in the prototype (B95-8) protein that are encoded by exons W2, Y1 and Y2 (removed by the genomic deletion in Daudi) are substituted by either two amino acids encoded by the U exon or 23 amino acids encoded by HF (see Fig. 4 (Dyson et aL, 1989) . At present, the significance of the predicted substitution of carboxy-terminal sequences in Daudi cells is unknown. The demonstration of multiple EBNA5 species in a single EBV-infected B cell line containing a normal B a m H I WYH region is probably due to their expression from mRNAs containing different numbers of W exons (Dillner et al., 1986; Speck et aL, 1986) . Since none of the cDNAs characterized in this study represent full-length copies of mRNAs, the exact number of W exons is unknown. However, the size difference between the two observed Daudi EBNA5 species (6K, corresponding to the size of a peptide encoded by one copy of the W1/W2 exon pair) would be consistent with this hypothesis. An alternative explanation that cannot be excluded, and is supported by data presented here, is that the two EBNA5 species are encoded by different messages containing the same number of W exons, but possessing alternative 3' coding exons, the larger protein being encoded by a message with a W1/HF exon junction (such as the one represented by the WHF1 clone), and the smaller species being encoded by messages exhibiting a W1/U exon junction (such as those represented by the WUL1 and WUE3.1 clones). The difference in the Mr of the HF and U-encoded peptides (calculated to be approximately 3K), however, is too small to explain the observed difference in size of the two Daudi EBNA5 species, assuming that the structures of these proteins (Fig. 4) do not result in anomalous migration on polyacrylamide gels. In this regard, it is interesting that the carboxyterminal amino acid from the H F exon is a potentially reactive cysteine residue. The inclusion of portions of the L and E3 exons in clones WUL1 and WUE3.1 suggests that these represent parts of the Daudi EBNA3 and EBNA6 messages, respectively. Similarly, the presence of HF exon sequences in clone WHF1 may indicate that ) and the primers used to amplify cDNAs by PCR (designated a to h). To conserve space, exons U to E4 are drawn to one-quarter of the scale of exons W0 to HF. The exons encoding EBNA3, EBNA6 and the BHRFl-encoded proteins are indicated. Cytoplasmic RNA (1 p~g), prepared from Daudi cells, was 'reversetranscribed' into cDNA using random hexamer oligonucleotides. The products of this reaction were then subjected to PCR amplification with primers a to h. The structures of five cDNA clones isolated, designated WOW l, WOW I'ATG, WHF1, WUL 1 and WUE3.1, are shown below the genome. The WOW1 and WOWI'ATG clones were amplified using primers a (5' GTTCTCGAGCGC-CAGGAGTCCA 3") and b (5" GTGCCTTCTTAGGAGCTGTC 3'), and differ solely by possession of either a W1 exon or a truncated form of this exon, known as Wl'. The selection of the W l ' acceptor creates the EBNA5 translational initiation codon. The WHF1 clone was amplified using primers c (5' ATTGAATTCTAAGAAGGCACCGGTCG Y) and d (5' CCCGAATTCTGGTTACAACACAA-TGTCC 3'). Clones WUL1 and WUE3.1 were generated by 'nested' PCR, WULI being generated by subjecting the products of amplification with primers a and f (5' CGTGAATTCTCCGACGATCTCTAATGGC 3') to a second round of amplification with primers c and e (5' TCCCAAGCTTCCGCCGATACCT 3"). In a similar fashion, clone WUE3.1 was generated by subjecting the products of amplification with primers a and h (5' TATCAAGCTTGATAGCGCTTG 3') to a second round of amplification with primers c and g (5' CTCTGAATTCATCACCCCTGCT 3'). Exons are indicated by solid bars and splicing is represented by the thin lines between the exons. An asterisk denotes that an incomplete copy of that particular exon exists in the clone. Note that, for conservation of space, only one copy of each of the W exons is shown in the representation of WHF1. This clone actually possessed four copies. this clone represents a message for the BHRFl-encoded protein. Since the clones obtained in this study were not derived from a cDNA library, but by PCR amplification, the clones may not represent the predominant EBNA transcripts expressed in Daudi cells.
It is noteworthy that multiple EBNA5 species have also been detected in P3HR-1 cells Wang et al., 1987) . Since the P3HR-1 virus possesses a similar genomic deletion to that in the Daudi strain of EBV, it is conceivable that the different P3HR-1 EBNA5 proteins are also encoded by messages containing different 3' exons. EBNA5 species have been reported that are larger in size than that predicted from the number of BamHI W fragments in an individual viral genome (Finke et al., 1987; Rooney et al., 1988; Allan & Rowe, 1989) . This also may be due to their carboxy termini being encoded by exons other than those derived from BamHI Y. Since EBNA5 clearly contributes to the efficiency of the B cell immortalization process (Hammerschmidt & Sugden, 1989; Mannick et al., 1991 ; Allan et al., 1992) , the biological significance of the mutated EBNA5 species in Daudi (or P3HR-1) cells warrants further investigation.
